TRANSLATIONAL RESEARCH IN KIDNEY DISEASES

Kirk Campbell, MD, is the Irene and Dr. Arthur Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai. He is a graduate of the University of Connecticut School of Medicine and completed residency training in Internal Medicine at Yale-New Haven Hospital. He completed a clinical nephrology fellowship and advanced research training in podocyte cell biology and experimental glomerular disease at Mount Sinai. In addition to treating patients with kidney disease, Dr. Campbell leads an NIH-funded research program focused on developing new therapeutic interventions for proteinuric diseases. He actively participates in clinical trials testing novel agents for primary glomerular disease and is an elected member of the American Society for Clinical Investigation. He is a Past-President of the New York Society of Nephrology, a member of the Board of Directors of the Nephcure Foundation, a standing member of the Pathobiology of Kidney Disease (PBKD) study section at the National Institutes of Health, the Medical Advisory Board of the National Kidney Foundation of Greater New York. He has served on the American Society of Nephrology Grants Review and Kidney Week Education Committees.